SUDA expands dialogue with World Health Organisation
Filed with ASX · · 2 pages · English
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- HC Berlin Pharma Update
- SUDA Completes Divestment of Subsidiary
- Divestment Of Non-Core Subsidiary
- New Analyst Report
- SUDA Completes Acquisition Of Anti-Cancer Agent
Later from Arovella Therapeutics
- SUDA announces update on ZolpiMist in USA and Canada
- SUDA Expands Patent Coverage For Sildenafil
- Shareholder Update
- Settlement with HC Berlin Pharma and Rights Issue
- Prospectus for a Renounceable Pro Rata Offer
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics